Coxsackie virus: Difference between revisions

(5 intermediate revisions by 3 users not shown)
Line 2: Line 2:


==Clinical Features==
==Clinical Features==
*[[Fever]], malaise, [[upper respiratory infection]], lymphadenopathy
*Brief prodrome with [[Fever]], malaise, [[upper respiratory infection]], lymphadenopathy
*Painful oral vesicles/ulcers/stomatitis ([[herpangina]])
*Common:
*Herpangina + lesions on hands and feet ([[Hand-foot-and-mouth disease]])
**[[Herpangina]]: painful oral vesicles with erythematous base which then ulcerate
*Parotitis
***Vesicles located in anterior oral cavity (most common on tongue and buccal mucosa)
*Orchitis
**[[Hand-foot-and-mouth disease]]: herpangina + red papules that become gray vesicles on hands and/or feet
*Acute [[pericarditis]]
*Less common:
*[[Myocarditis]]
**[[Parotitis]]
**[[Orchitis]]
**Acute [[pericarditis]]
**[[Myocarditis]]
**[[Meningitis]], [[encephalitis]]
**Some children get a desquamation of the nails around 2 weeks afterwards (self resolves)


==Differential Diagnosis==
==Differential Diagnosis==
{{Peds Rash DDX}}
{{Bullous rashes DDX}}


==Evaluation==
==Evaluation==
*Clinical diagnosis, based on history and physical examination
**If unsure, see [[Pediatric Fever]]


==Management==
==Management==
 
*No specific therapy for most; self-limited
*[[NSAIDS]] and cool liquids for pain
*Encourage good hand hygiene to prevent spread
*Some recommend Magic Mouthwash/oral lidocaine if not tolerating PO intake, although evidence suggests no better than placebo<ref>Hopper S. et al. Topical lidocaine to improve oral intake in children with painful infectious mouth ulcers: a blinded, randomized, placebo-controlled trial. Ann Emerg Med. 2014 Mar;63(3):292-9</ref>
'''In infants, do NOT use oral lidocaine due to risk of lidocaine toxicity and FDA black box warning'''<ref>FDA recommends not using lidocaine to treat teething pain. http://www.fda.gov/Drugs/DrugSafety/ucm402240.htm</ref><ref>Curtis LA, Dolan TS, Seibert HE. Are one or two dangerous? Lidocaine and topical anesthetic exposures in children. J Emerg Med 2009;37:32-39</ref>
==Disposition==
==Disposition==
*Discharge with close outpatient followup to ensure adequate PO intake.


==See Also==
==See Also==
*[[Pediatric fever]]
*[[Hand-foot-and-mouth disease]]
*[[Herpangina]]
*[[Enteroviral Infections]]
*[[Pediatric Rashes]]


==External Links==
==External Links==
Line 24: Line 43:
==References==
==References==
<references/>
<references/>
[[Category:ID]]

Revision as of 17:49, 20 August 2017

Background

Clinical Features

Differential Diagnosis

Pediatric Rash

Vesiculobullous rashes

Febrile

Afebrile

Evaluation

  • Clinical diagnosis, based on history and physical examination

Management

  • No specific therapy for most; self-limited
  • NSAIDS and cool liquids for pain
  • Encourage good hand hygiene to prevent spread
  • Some recommend Magic Mouthwash/oral lidocaine if not tolerating PO intake, although evidence suggests no better than placebo[1]

In infants, do NOT use oral lidocaine due to risk of lidocaine toxicity and FDA black box warning[2][3]

Disposition

  • Discharge with close outpatient followup to ensure adequate PO intake.

See Also

External Links

References

  1. Hopper S. et al. Topical lidocaine to improve oral intake in children with painful infectious mouth ulcers: a blinded, randomized, placebo-controlled trial. Ann Emerg Med. 2014 Mar;63(3):292-9
  2. FDA recommends not using lidocaine to treat teething pain. http://www.fda.gov/Drugs/DrugSafety/ucm402240.htm
  3. Curtis LA, Dolan TS, Seibert HE. Are one or two dangerous? Lidocaine and topical anesthetic exposures in children. J Emerg Med 2009;37:32-39